Immunexpress Funding History

Since Immunexpress was founded in 2006, it has participated in 3 rounds of funding. In total Immunexpress has raised $46.0M. Immunexpress' last funding round was on Oct 2019 for a total of $0.

Immunexpress Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Unattributed
Oct 2019
--
1
Series C
Apr 2015
$40M
__
Equity
Mar 2014
$6M
1

Immunexpress Investors

INVESTOR

ROUND

FUNDING DATE

Equity
Mar 2014
Immunexpress has 2 investors, including U.S. Food and Drug Administration and Debiopharm Group. The latest investment occurred in Oct 2019.